Glenmark Pharmaceuticals posted a net profit of Rs 226.784 crore for the quarter-ended June, against Rs 182.945 crore in the year-ago period; an increase of 23.96 per cent.
The company's consolidated revenue was Rs 1,943.1 crore, against Rs 1,647.7 crore in the year-ago period, up 17.92 per cent. Sales in India grew 10 per cent to Rs 513.766 crore against Rs 465.425 crore in the year-ago period.
